The effects of infliximab or adalimumab on vascular endothelial growth factor and angiopoietin 1 angiogenic factor levels in inflammatory bowel disease: Serial observations in 37 patients

1. Algaba, A.
2. Linares, P.M.
3. Fernández-Contreras, M.E.
4. Figuerola, A.
5. Calvet, X.
6. Guerra, I.
7. De Pousa, I.
8. Chaparro, M.
9. Gisbert, J.P.
10. Bermejo, F.